About 600 reports

  • PHARMACEUTICALS IN THE UNITED KINGDOM
  • DRIVERS OF BUYER POWER IN THE PHARMACEUTICALS MARKET IN THE UNITED KINGDOM, 2017

Pharmaceuticals Global Group of Eight (G8) Industry Guide 2013-2022 Summary The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions...

  • Pharmaceutical
  • United Kingdom
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (ABPI)
  • UNITED KINGDOM PHARMACEUTICALS MARKET VALUE: $ BILLION, 2013-17

Pharmaceuticals in the United Kingdom Summary Pharmaceuticals in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading...

  • Pharmaceutical
  • United Kingdom
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • Pharma as a Driver of the UK Economy
  • The UK Pharma Industry A Key Driver of the UK Economy

Brexit and the Healthcare Industry - Implications for Pharma, Q1 2018 Summary It has been almost two years since the UK voted to leave the EU.Businesses were told a vote to leave the EU would drive the UK into a severe recession, yet markets are up. Negotiations are ongoing to determine the...

  • Pharmaceutical
  • United Kingdom
  • Market Size
  • AstraZeneca PLC
  • Novartis AG
  • PHARMACEUTICALS IN THE UNITED KINGDOM
  • DRIVERS OF SUPPLIER POWER IN THE PHARMACEUTICALS MARKET IN THE UNITED KINGDOM, 2015

Summary The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the...

  • Pharmaceutical
  • United Kingdom
  • Market Size
  • AstraZeneca PLC
  • Bayer AG
  • PHOSPHATE THERAPEUTICS ENTERS INTO LICENSING AGREEMENT WITH MEDICAL RESEARCH COUNCIL FOR PT20
  • May 17, 2016: Psilocybin for treatment-resistant depression

GlobalData Region Europe Asia-Pacific Middle East and Africa North America South and Central America No. of Deals ## ## ## ## ## Deal Value (US$ million) NA NA NA NA NA Medical Research Council, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to

  • Pharmaceutical
  • United Kingdom
  • Social Conditions
  • AstraZeneca PLC
  • GlobalData's company
  • Walgreens Boots Alliance Inc | AAH Pharmaceuticals Ltd Phoenix Healthcare Distribution Ltd | Other Companies
  • About this Industry

Unhealthy prospects: Constrained growth in NHS spending is expected to restrict expansion Abstract Pharmaceutical Wholesaling in the UK This industry covers businesses that wholesale pharmaceuticals or medical goods. These are distributed to pharmacies, specialist retailers, hospitals,...

  • Pharmaceutical
  • United Kingdom
  • Demand
  • Forecast
  • Supply
  • NOVARTIS PHARMACEUTICALS UK LTD - FINANCIAL PERFORMANCE
  • NOVARTIS PHARMACEUTICALS UK LTD - FINANCIAL PERFORMANCE

A poor prognosis: The loss of patent protection keeps the industry feeling under the weather Abstract Pharmaceutical Preparations Manufacturing in the UK This industry includes companies that manufacture medications, chemical contraceptive products, medical diagnostic preparations,...

  • Pharmaceutical
  • United Kingdom
  • Forecast
  • AstraZeneca PLC
  • Novartis AG
  • Despite the importance of the pharmaceutical sector, volatile revenue has declined overall
  • Major market segmentation (2018-19)

Bad treatment: Strong import competition has contributed towards revenue decline Abstract Basic Pharmaceutical Product Manufacturing in the UK Companies in the Basic Pharmaceutical Product Manufacturing industry manufacture medicinal active substances that are used for their pharmacological...

  • Pharmaceutical
  • United Kingdom
  • Demand
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Value (GBP Million), 2012 - 2021
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Volume (Million Square Feet), 2012 - 2021

The industrial building construction market in value terms is expected to reach US$ 14.5 billion in 2017. This report from ConsTrack360 provides data, analyses and opinion on industrial construction industry, with over 40 KPIs. It details market size & forecast, growth drivers, emerging trends, market opportunities, and investment risks...

  • Construction
  • Pharmaceutical
  • United Kingdom
  • Forecast
  • Market Size
  • Timetric- Chemical and Pharmaceutical Plants construction Market Definitions
  • 2.3 Overall Chemical and Pharmaceutical Plants construction Output,

Synopsis Timetric’s "Chemical and Pharmaceutical Plants (Construction) in the United Kingdom: Market Analytics by Category & Cost Type to 2022" contains historic and forecast market data for the chemical and pharmaceutical plants category in United Kingdom, it also provides detailed breakdown of the data by construction...

  • Construction
  • Pharmaceutical
  • United Kingdom
  • Market Size
  • Supply
  • 2.2 Overall Chemical and Pharmaceutical Plants construction Output
  • 2.3 Overall Chemical and Pharmaceutical Plants construction Output,

Synopsis Timetric’s "Chemical and Pharmaceutical Plants (Construction) in United Kingdom: Market Analytics by Category & Cost Type to 2021" contains historic and forecast market data for the chemical and pharmaceutical plants category in United Kingdom, it also provides detailed breakdown of the data by construction activity...

  • Construction
  • Pharmaceutical
  • United Kingdom
  • Market Size
  • Supply
  • PHARMACEUTICALS IN THE UNITED KINGDOM
  • UNITED KINGDOM PHARMACEUTICALS MARKET SHARE: % SHARE, BY VALUE, 2014

Introduction The G8 Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2019). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the...

  • Pharmaceutical
  • United Kingdom
  • Market Size
  • AstraZeneca PLC
  • Bayer AG
  • PRICE BUILD UP
  • PHARMACOECONOMICS

In 2014, for example, Leo Pharma announced that it would distribute its products solely via Alliance with effect from ## October 2014.

  • Hospital
  • Pharmaceutical
  • Therapy
  • United Kingdom
  • Institute of Cancer Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Summary Institute of Cancer Research (ICR), a subsidiary of University of London is a research institute that offers cancer research and education programs.The institute conducts research and develops new therapies for the treatment of cancer including breast and lung cancer. It offers various postgraduate and higher...

  • Breast Cancer
  • Pharmaceutical
  • United Kingdom
  • Cancer Research Technology Limited
  • Merck Serono S.A.
  • 3 CHEMICAL AND PHARMACEUTICAL PLANTS CONSTRUCTION: ACTIVITY ANALYSIS
  • 2 CHEMICAL AND PHARMACEUTICAL PLANTS CONSTRUCTION: CATEGORY DATA

Synopsis Timetric’s 'Chemical and Pharmaceutical Plants Construction in the UK to 2020: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance,...

  • Construction
  • Pharmaceutical
  • United Kingdom
  • Market Size
  • Supply

2018 and Beyond: United Kingdom Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 ## Table of Contents ##. ## List of Tables ##. ## List of Figures ## Executive Summary ##. ## United Kingdom Pharmaceutical and Healthcare Industry Snapshot ##. ## United Kingdom

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Demand
  • Market Size
  • 4.2 Pharmaceutical & Healthcare Online Ad Spend
  • UK PHARMACEUTICAL & HEALTHCARE BRANDS' ONLINE ADVERTISING SPEND (US$ MILLION), 2011-2020

Online advertising spend by pharmaceutical & healthcare brands in the UK stood at US$384 million by end of 2015, accounting for 2.9% of total online advertising. During 2011-2015, online advertising in this industry has increased at a CAGR of 10.7%. This growth is expected to continue in 2016 with brands expected to spend US$418 million, representing...

  • M-Commerce
  • Online Advertising
  • Pharmaceutical
  • United Kingdom
  • Forecast
  • United Kingdom generics market volume forecast: % of total pharma volume, 2016-21
  • United Kingdom generics market volume forecast: % of total pharma volume, 2016-21

Generics Global Group of Eight (G8) Industry Guide 2017-2021 Summary The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players...

  • Pharmaceutical
  • East Asia
  • United Kingdom
  • Daiichi Sankyo Company
  • Mylan Inc.
  • 5.2 Pharmaceutical & Healthcare Social Media Ad Spend
  • UK PHARMACEUTICAL & HEALTHCARE BRANDS' ADVERTISING SPEND ON SOCIAL MEDIA (US$ MILLION), 2011-2020

Social media advertising spend by pharmaceutical & healthcare brands in the UK stood at US$43 million by end of 2015, accounting for 2.6% of total social media advertising. During 2011-2015, social media advertising in this industry has increased at a CAGR of 34.1%. This growth is expected to continue in 2016 with brands expected to spend...

  • Advertising
  • Pharmaceutical
  • Social Network
  • United Kingdom
  • Forecast

Pharmaceutical and Biotechnology Construction Sector Report - UK 2016-2020 Analysis ##.

  • Construction
  • Pharmaceutical
  • United Kingdom
  • Market Size
  • Supply
  • JAN 24, 2018: ALMAC GROUP LAUNCHES BESPOKE ELEMENTAL IMPURITIES LABORATORY
  • ALMAC GROUP LTD - KEY COMPETITORS

Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 Almac Group Ltd' s, deal volume increased from one pharmaceuticals & healthcare deal in 2016 to four pharmaceuticals & healthcare deals in 2017.

  • Pharmaceutical
  • United Kingdom
  • Supply
  • Almac Discovery Ltd.
  • Galen Limited
  • The Association of the British Pharmaceutical Industry (ABPI)
  • Teva Pharmaceutical Industries Limited: revenues & profitability

Generics in the United Kingdom Summary Generics in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including...

  • Pharmaceutical
  • United Kingdom
  • Mylan Inc.
  • Novartis AG
  • Pfizer Inc.
  • UNITED KINGDOM GENERICS MARKET VOLUME FORECAST: % OF TOTAL PHARMA VOLUME, 2016-21
  • UNITED KINGDOM GENERICS MARKET VOLUME FORECAST: % OF TOTAL PHARMA VOLUME, 2016-21

Generics Global Group of Eight (G8) Industry Guide_2017 Summary The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including...

  • Pharmaceutical
  • North America
  • United Kingdom
  • United States
  • Western Europe
  • 4.1 Chemical and Pharmaceutical Plants construction Output Value,
  • 4.3 Chemical and Pharmaceutical Plants construction Output, by Cost

Synopsis Timetric’s "Industrial Construction Market in the United Kingdom: Market Size, Growth and Forecast Analytics to 2022" contains historic and forecast market data for the industrial construction market in United Kingdom, with a detailed breakdown of the data by construction activity (new construction, repair and...

  • Construction
  • Pharmaceutical
  • United Kingdom
  • Market Size
  • Supply

ONE ICE SYSTEM REFERS TO ONE CONSOLE.

  • Pharmaceutical
  • United Kingdom
  • Market Size
  • Biosense Webster, Inc.
  • Boston Scientific Corporation
  • TILLOTTS PHARMA'S UC PORTFOLIO ASSESSMENT, 2015
  • Executive Summary

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of the colon and rectum. As a result, the colon’s ability to absorb water is decreased, which leads to progressive loosening...

  • Pharmaceutical
  • Spain
  • United Kingdom
  • Pfizer Inc.
  • Remicade group
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Value (GBP Million), 2013 - 2022
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Volume (Million Square Feet), 2013 - 2022

Report Description The construction industry in value terms is expected to record a CAGR of 8.3% to reach US$ 408.9 billion by 2022. The industrial building construction market in value terms is expected to reach US$ 14.8 billion in 2018. This report from ConsTrack360 provides data-centric analyses on industrial...

  • Industrial Construction
  • Pharmaceutical
  • United Kingdom
  • Forecast
  • Market Size
  • SANOFI SA: KEY FACTS
  • DRIVERS OF DEGREE OF RIVALRY IN THE BIOTECHNOLOGY INDUSTRY IN THE UNITED KINGDOM, 2017

AstraZeneca has one business segment: biopharmaceuticals.

  • Pharmaceutical
  • United Kingdom
  • AstraZeneca PLC
  • GE Healthcare Limited
  • Novartis AG
  • Pharma and biotech
  • Pharmaceutical sales

Disease trends;Healthcare;Healthcare;Pharmaceuticals and biotechnology;Healthcare;Provision NCAIS: 62 SIC: 80

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Demand
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Volume (Million Square Feet), 2013 - 2022
  • Chemical & Pharmaceutical Building Average Construction Value (GBP / Square Feet), 2013 - 2022

Report Description The non residential construction industry in value terms increased at a CAGR of 7.2% during 2013-2017. The commercial building construction market in value terms is expected to record a CAGR of 5.5% over the forecast period. The industrial building construction market in value terms is expected to reach...

  • Commercial Construction
  • Pharmaceutical
  • United Kingdom
  • Forecast
  • Market Size